United States Endobronchial Ultrasound Biopsy Market to Reach US$ 249.8 Million by 2031 | North America leads with 40% share | Top Companies - Olympus Corporation, Medtronic, CLINODEVICE

Leander, Texas and Tokyo, Japan - Jan.28.2026
As per DataM intelligence research report "The Global Endobronchial Ultrasound Biopsy Market reached US$ 576.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 832.7 million by 2031."

The market is driven by increasing lung cancer diagnosis and minimally invasive diagnostic procedures. Hospitals dominate adoption due to specialized equipment requirements. Rising awareness of early cancer detection supports growth.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/endobronchial-ultrasound-biopsy-market?prasad
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Endobronchial Ultrasound Biopsy Market: Competitive Intelligence
Olympus Corporation, Medtronic, CLINODEVICE, CONMED Corporation, Medi-Globe GmbH, Boston Scientific Corporation, Serpex Medical

In the Endobronchial Ultrasound (EBUS) Biopsy Market, Olympus Corporation, Medtronic, CLINODEVICE, CONMED Corporation, Medi-Globe GmbH, Boston Scientific Corporation, and Serpex Medical are key players providing advanced diagnostic and interventional solutions for lung cancer, thoracic diseases, and lymph node assessment. These companies develop EBUS bronchoscopes, biopsy needles, and imaging systems that enable minimally invasive, real-time visualization and tissue sampling of the respiratory tract. Their focus on precision, safety, and procedural efficiency reinforces the Endobronchial Ultrasound Biopsy Market as a critical segment in pulmonary diagnostics and interventional pulmonology.

The market is strengthened by complementary capabilities across device innovation, imaging technology, and clinical support. Olympus Corporation and Boston Scientific Corporation lead with high-resolution EBUS systems and compatible biopsy tools for accurate tissue sampling. Medtronic and CONMED Corporation provide advanced minimally invasive platforms, imaging integration, and procedural support for thoracic interventions. CLINODEVICE and Serpex Medical focus on specialized biopsy needles and accessory devices that enhance procedural efficiency and patient safety. Medi-Globe GmbH contributes high-quality bronchoscopy instruments and visualization systems for clinical adoption in hospitals and diagnostic centers.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/endobronchial-ultrasound-biopsy-market?prasad
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Fund Raisings

✅ January 2026 - Veran Medical Technologies (United States)
Veran Medical Technologies raised growth funding to advance image-guided bronchoscopy and EBUS-enabled biopsy solutions. The capital supports product innovation and expanded adoption in pulmonary diagnostics.

✅ December 2025 - Intuitive Surgical (United States)
Intuitive Surgical allocated strategic investment toward development of robotic-assisted bronchoscopy and EBUS-compatible biopsy tools. The funding strengthens minimally invasive lung cancer diagnostic capabilities.

✅ November 2025 - Olympus Corporation (Japan)
Olympus Corporation committed internal R&D funding to expand its endobronchial ultrasound and pulmonary imaging portfolio. The investment supports next-generation visualization and biopsy precision technologies.

Product Launches & Partnerships

✅ January 2026 - Olympus America (United States)
Olympus America launched an enhanced EBUS bronchoscope system with improved ultrasound imaging and needle compatibility. The system supports more accurate lymph node staging and biopsy procedures.

✅ December 2025 - Fujifilm Healthcare (Japan)
Fujifilm Healthcare introduced advanced ultrasound processing technology for endobronchial diagnostic applications. The solution improves image clarity and real-time guidance during biopsy procedures.

✅ October 2025 - Boston Scientific (United States)
Boston Scientific expanded its pulmonary diagnostics portfolio with EBUS-compatible biopsy needles and accessories. The products aim to improve tissue acquisition and procedural efficiency.

Mergers & Acquisitions

✅ January 2026 - Intuitive Surgical (United States)
Intuitive Surgical acquired a minority stake in a pulmonary navigation technology company to enhance bronchoscopy and biopsy integration. The move strengthens its position in minimally invasive lung diagnostics.

✅ November 2025 - Olympus Corporation (Japan)
Olympus Corporation acquired a diagnostic imaging software firm focused on real-time ultrasound analytics. The acquisition enhances EBUS workflow efficiency and clinical decision support.

✅ October 2025 - Medtronic (United States)
Medtronic completed the acquisition of a respiratory intervention company specializing in biopsy and airway access technologies. The deal expands its interventional pulmonology portfolio.

Segment Covered in the Endobronchial Ultrasound Biopsy Market:
By Product Type
The market is segmented into Biopsy Needles 50%, Biopsy Forceps 35%, and Transbronchial Aspiration Needles 15%, with biopsy needles dominating due to precision in tissue sampling, widespread adoption in lung cancer diagnosis, and compatibility with EBUS procedures. Biopsy forceps are commonly used for less invasive procedures, while transbronchial aspiration needles serve specialized diagnostic needs.

By Application
Applications comprise Lung Cancer Diagnosis 60%, Lung Infection Diagnosis 25%, and Others 15%, with lung cancer diagnosis driving demand due to rising incidence globally, early detection initiatives, and adoption of minimally invasive diagnostic techniques. Lung infection diagnosis is growing with the increasing prevalence of respiratory diseases and chronic infections.

By End-User
End-users include Hospitals 70%, Diagnostic Laboratories 20%, and Others 10%, with hospitals dominating due to advanced bronchoscopic facilities, specialist pulmonologists, and integrated EBUS suites. Diagnostic laboratories are gaining adoption for outpatient and referral-based procedures.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=endobronchial-ultrasound-biopsy-market
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Regional Analysis
North America - ~40% Share
North America leads with 40% share driven by advanced healthcare infrastructure, high lung cancer prevalence, and adoption of minimally invasive procedures in the U.S. and Canada. Hospitals are primary end-users, and biopsy needles dominate product adoption.

Europe - ~25% Share
Europe holds 25% share supported by widespread diagnostic facilities, lung cancer screening programs, and investments in advanced bronchoscopy systems in Germany, France, and the UK.

Asia Pacific - ~20% Share
Asia Pacific captures 20% share fueled by increasing lung cancer incidence, expanding healthcare infrastructure, and rising awareness of early diagnostic procedures in China, Japan, India, and Southeast Asia.

Latin America - ~10% Share
Latin America represents 10% share driven by adoption in hospitals and specialty diagnostic centers in Brazil, Mexico, and Argentina. Lung cancer diagnosis remains the key application.

Middle East & Africa - ~5% Share
Middle East & Africa holds 5% share, supported by growing healthcare infrastructure, adoption in private hospitals, and rising awareness of minimally invasive lung diagnostics in GCC countries and South Africa.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.